Amesite Shares Surge Over 100% Following NurseMagic Expansion and Launch of New AI Tool for Automating Government Forms
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 11 2025
0mins
Source: SeekingAlpha
Revenue Growth: Amesite reported a 63% revenue growth from its NurseMagic enterprise product, with enterprise sales now exceeding B2C sales due to increased demand from post-acute care providers.
New AI Tool Launch: The company announced the launch of an AI-powered tool for automating government form-filling, addressing the rising scrutiny of documentation and the upcoming HOPE requirement for compliant submissions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AMST?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AMST
About AMST
Amesite Inc. is a technology company. The Company is specialized in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. It has products in two sectors: Higher Education and Healthcare. It offers cutting-edge applications that cater to both individual and professional needs. The Company’s NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Clearwater Analytics (CWAN) Acquired by Private Equity Consortium for $8.4 Billion
- Acquisition Announcement: A consortium of private equity firms led by Permira and Warburg Pincus has announced a deal to acquire Clearwater Analytics for approximately $8.4 billion, including debt, indicating strong market interest in investment and accounting software companies.
- Stock Price Reaction: Clearwater Analytics shares surged 7.6% to $23.93 in pre-market trading, reflecting positive investor sentiment regarding the acquisition news, which may enhance the company's future market performance.
- Market Impact: This acquisition not only provides Clearwater Analytics with financial backing but also has the potential to accelerate its technological innovation and market expansion, strengthening its position in the highly competitive software industry.
- Industry Trend: With private equity firms continuing to invest in the software sector, more similar transactions are expected, further consolidating market resources and enhancing industry competitiveness.
Continue Reading
Amesite Launches NurseMagic™ EMR, Achieves 82% Revenue Growth
- Product Expansion: Amesite's launch of the NurseMagic™ EMR marks a significant platform expansion, with customer onboarding expected to begin in January 2026, further solidifying its position in the post-acute care market.
- Revenue Growth: Following the May 2025 launch of Teams+, quarterly revenue surged 2.4x, and after the introduction of the Enterprise tier in Q4 2025, revenues increased by 82%, demonstrating the market appeal of higher-value offerings.
- Market Potential: The U.S. post-acute care market was valued at over $470 billion in 2024 and is projected to exceed $850 billion in the coming years, driven primarily by an aging population and rising chronic disease burdens.
- Customer Flexibility: The new EMR system allows for coexistence with existing systems or complete replacement, providing flexibility to meet customer needs, thereby enhancing Amesite's competitive sales advantage.
Continue Reading